Aerovate Therapeutics

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.25-$32.41
Market Cap
$68.6M
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$2.99

News

See more

Yahoo Finance • 5 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders

Yahoo Finance • 27 days ago

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders

Yahoo Finance • 28 days ago

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger - IPG, VTS, AVTE, MHLD

Yahoo Finance • last year

Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension

About

CEO
Mr. Timothy P. Noyes M.B.A.
CFO
Mr. George A. Eldridge
Address
930 Winter Street, Waltham, MA, United States, 02451
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
51